Literature DB >> 15067078

Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.

Raffaella Bonecchi1, Massimo Locati, Emanuela Galliera, Marisa Vulcano, Marina Sironi, Anna M Fra, Marco Gobbi, Annunciata Vecchi, Silvano Sozzani, Bodduluri Haribabu, Jo Van Damme, Alberto Mantovani.   

Abstract

The promiscuous D6 receptor binds several inflammatory CC chemokines and has been recently proposed to act as a chemokine-scavenging decoy receptor. The present study was designed to better characterize the spectrum of CC chemokines scavenged by D6, focusing in particular on CCR4 ligands and analyzing the influence of NH(2)-terminal processing on recognition by this promiscuous receptor. Using D6 transfectants, it was found that D6 efficiently bound and scavenged most inflammatory CC chemokines (CCR1 through CCR5 agonists). Homeostatic CC chemokines (CCR6 and CCR7 agonists) were not recognized by D6. The CCR4 agonists CC chemokine ligand 17 (CCL17) and CCL22 bound to D6 with high affinity. CCL17 and CCL22 have no agonistic activity for D6 (chemotaxis and calcium fluxes), but were rapidly scavenged, resulting in reduced chemotactic activity on CCR4 transfectants. CD26 mediates NH(2) terminus processing of CCL22, leading to the production of CCL22 (3-69) and CCL22 (5-69) that do not interact with CCR4. These NH(2)-terminal truncated forms of CCL22 were not recognized by D6. The results presented in this study show that D6 recognizes and scavenges a wide spectrum of inflammatory CC chemokines, including the CCR4 agonists CCL22 and CCL17. However, this promiscuous receptor is not engaged by CD26-processed, inactive, CCL22 variants. By recognizing intact CCL22, but not its truncated variants, D6 expressed on lymphatic endothelial cells may regulate the traffic of CCR4-expressing cells, such as dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067078     DOI: 10.4049/jimmunol.172.8.4972

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  The attraction of chemokines as a target for specific anti-inflammatory therapy.

Authors:  James E Pease; Timothy J Williams
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 2.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

3.  A silent chemokine receptor regulates steady-state leukocyte homing in vivo.

Authors:  Kornelia Heinzel; Claudia Benz; Conrad C Bleul
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

4.  Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

Authors:  Yeny Martinez de la Torre; Chiara Buracchi; Elena M Borroni; Jana Dupor; Raffaella Bonecchi; Manuela Nebuloni; Fabio Pasqualini; Andrea Doni; Eleonora Lauri; Chiara Agostinis; Roberta Bulla; Donald N Cook; Bodduluri Haribabu; Pierluigi Meroni; Daniel Rukavina; Luca Vago; Francesco Tedesco; Annunciata Vecchi; Sergio A Lira; Massimo Locati; Alberto Mantovani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

5.  Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells.

Authors:  Susanne Stutte; Thomas Quast; Nancy Gerbitzki; Terhi Savinko; Nina Novak; Julia Reifenberger; Bernhard Homey; Waldemar Kolanus; Harri Alenius; Irmgard Förster
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

6.  Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.

Authors:  Rosa Barreira da Silva; Melissa E Laird; Nader Yatim; Laurence Fiette; Molly A Ingersoll; Matthew L Albert
Journal:  Nat Immunol       Date:  2015-06-15       Impact factor: 25.606

7.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

8.  Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.

Authors:  Antal Rot; Clive McKimmie; Claire L Burt; Kenneth J Pallas; Thomas Jamieson; Monika Pruenster; Richard Horuk; Robert J B Nibbs; Gerard J Graham
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

9.  Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.

Authors:  Benedetta Savino; Elena Monica Borroni; Nina Machado Torres; Paul Proost; Sofie Struyf; Anneleen Mortier; Alberto Mantovani; Massimo Locati; Raffaella Bonecchi
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

10.  A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis.

Authors:  Glenda Trujillo; Erica C O'Connor; Steven L Kunkel; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.